Our latest publication demonstrated that high expression of EP3 is associated with poor prognosis in overall survival rates of cervical cancer patients in both squamous cell carcinoma and adenocarcinoma (Heidegger et al. 2017). This evidence concerns the gene PTGER3 and cervical carcinoma.